Skip to main content

Table 11 Aromatse inhibitory activity of isflavaone derivatives (33–35)

From: Estrogen alpha receptor antagonists for the treatment of breast cancer: a review

Compound No.

Aromatase inhibitory activity

IC50 = µM

33

2.4

34

0.26

35

5.8